Free Trial

Insider Selling: Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sells 34,100 Shares of Stock

Viemed Healthcare logo with Medical background

Viemed Healthcare, Inc. (NASDAQ:VMD - Get Free Report) Director Nitin Kaushal sold 34,100 shares of the business's stock in a transaction that occurred on Friday, June 27th. The stock was sold at an average price of $7.01, for a total value of $239,041.00. Following the completion of the transaction, the director owned 126,843 shares in the company, valued at $889,169.43. The trade was a 21.19% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Nitin Kaushal also recently made the following trade(s):

  • On Thursday, June 26th, Nitin Kaushal sold 8,852 shares of Viemed Healthcare stock. The stock was sold at an average price of $7.00, for a total value of $61,964.00.

Viemed Healthcare Stock Performance

Shares of Viemed Healthcare stock traded down $0.01 during trading hours on Monday, hitting $6.91. 462,752 shares of the company's stock traded hands, compared to its average volume of 143,649. The stock has a market capitalization of $273.08 million, a price-to-earnings ratio of 23.03 and a beta of 1.38. Viemed Healthcare, Inc. has a 12-month low of $6.14 and a 12-month high of $9.81. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.38 and a quick ratio of 1.26. The company has a fifty day simple moving average of $6.78 and a 200-day simple moving average of $7.39.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.06. The business had revenue of $59.10 million during the quarter, compared to the consensus estimate of $60.60 million. Viemed Healthcare had a net margin of 5.28% and a return on equity of 9.49%.

Institutional Investors Weigh In On Viemed Healthcare

Hedge funds have recently modified their holdings of the stock. Strs Ohio bought a new position in Viemed Healthcare during the first quarter worth about $443,000. Jane Street Group LLC purchased a new position in shares of Viemed Healthcare during the 1st quarter valued at $394,000. AQR Capital Management LLC purchased a new position in Viemed Healthcare during the first quarter worth about $90,000. Apis Capital Advisors LLC increased its position in shares of Viemed Healthcare by 8.7% in the first quarter. Apis Capital Advisors LLC now owns 304,000 shares of the company's stock worth $2,213,000 after purchasing an additional 24,400 shares during the last quarter. Finally, Panagora Asset Management Inc. lifted its holdings in shares of Viemed Healthcare by 14.2% during the 1st quarter. Panagora Asset Management Inc. now owns 235,814 shares of the company's stock worth $1,717,000 after acquiring an additional 29,252 shares during the last quarter. Institutional investors own 74.24% of the company's stock.

About Viemed Healthcare

(Get Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Viemed Healthcare Right Now?

Before you consider Viemed Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.

While Viemed Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Defense Stocks Under $10 With Massive Upside
NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines